Premier statement on drug compounding in advance of 7/16 House Subcommittee meeting Last Updated: July 24, 2014
Filed under:
Print Friendly, PDF & Email

The Premier healthcare alliance submitted a statement to the House Energy and Commerce Committee Health Subcommittee on reforming the regulatory framework of drug compounding.

For Immediate Release

Charlotte, N.C.

Earlier today, the Premier healthcare alliance submitted a compounding statement to the House Energy and Commerce Committee Health Subcommittee in advance of tomorrow’s hearing on reforming the regulatory framework of drug compounding.

About Premier Inc.

Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other provider organizations. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.

Contacts

Amanda Forster, Premier, Inc.   |   amanda_forster@premierinc.com   |   202.879.8004
Morgan Guthrie, Premier, Inc.   |   morgan_guthrie@premierinc.com   |   704.816.4152